US Patent 10912287 Genetically modified mice expressing humanized PD-1
Patent 10912287 was granted and assigned to Biocytogen on February, 2021 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10912287 Genetically modified mice expressing humanized PD-1
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.